American Urogynecologic Society
13
2
2
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 70/100
30.8%
4 terminated/withdrawn out of 13 trials
55.6%
-30.9% vs industry average
15%
2 trials in Phase 3/4
140%
7 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
SORE Study: Sitz Baths After Urogynecologic Reconstruction
Role: collaborator
At-Home Transcutaneous Tibial Nerve Stimulation for Overactive Bladder in Rural Women
Role: collaborator
Smartphone-based Self-care Education Program for Women With Interstitial Cystitis: Educational Remote IC Aide
Role: collaborator
Vaginal Estrogen and Pelvic Floor Physical Therapy in Women With Symptomatic Mild Prolapse
Role: collaborator
Sacral Neuromodulation and the Microbiome
Role: collaborator
Transcutaneous Tibial Nerve Stimulation for Urgency Urinary Incontinence
Role: collaborator
Sacral Neuromodulation in Dual Incontinence: Ultrasound and Afferent Nerve Sensation Assessment
Role: collaborator
Ultrasound and EMG Guided Botox Injection for the Treatment of Non-Relaxing Puborectalis Syndrome
Role: collaborator
Optimization of Spontaneous Postoperative Trial of Void Among Women
Role: collaborator
Vaginal Estrogen for the Prevention of Recurrent Urinary Tract Infection in Postmenopausal Women
Role: collaborator
Prevention of Catheter-Associated Urinary Tract Infection in Incontinence and Reconstructive Pelvic Surgery Patients
Role: collaborator
The Effect of Anticholinergics on Cognitive Function in the Elderly
Role: collaborator
MiraLAX Versus Placebo to Prevent Constipation Following Urogynecologic Surgery
Role: collaborator
All 13 trials loaded